US Stock MarketDetailed Quotes

GERN Geron

Watchlist
  • 1.605
  • -0.005-0.31%
Trading Feb 27 10:54 ET
970.22MMarket Cap-5.94P/E (TTM)

About Geron Company

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Company Profile

SymbolGERN
Company NameGeron
Listing DateJul 30, 1996
Issue Price8.00
Founded1990
CEODr. John A. Scarlett,M.D.
MarketNASDAQ
Employees141
Fiscal Year Ends12-31
Address919 East Hillsdale Boulevard,Suite 250
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-473-7700

Company Executives

  • Name
  • Position
  • Salary
  • Dr. John A. Scarlett,M.D.
  • Chairman of the Board, Chief Executive Officer and President
  • 4.92M
  • Scott A. Samuels
  • Executive Vice President, Chief Legal Officer and Corporate Secretary
  • 3.61M
  • Anil Kapur
  • Executive Vice President, Corporate Strategy and Chief Commercial Officer
  • --
  • Melissa A. Kelly Behrs
  • Executive Vice President, Business Operations and Chief Alliance Officer
  • --
  • Dr. Faye Feller
  • Executive Vice President and Chief Medical Officer
  • --
  • Dr. Andrew J. Grethlein,PhD
  • Executive Vice President and Chief Operating Officer
  • 2.42M
  • Shannon T. Odam
  • Senior Vice President and Chief People Officer
  • --
  • Michelle Robertson
  • Executive Vice President, Finance, Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 2.47M
  • Edward E. Koval
  • Executive Vice President and Chief Business Officer
  • --
  • Elizabeth G. O’Farrell
  • Lead Independent Director
  • 375.53K
  • Dr. Susan M. Molineaux, PhD
  • Independent Director
  • 345.90K
  • Dr. Robert J. Spiegel, F.A.C.P.,M.D.
  • Independent Director
  • 350.90K
  • Dawn Carter Bir
  • Independent Director
  • 343.12K
  • John F. McDonald
  • Independent Director
  • 348.40K
  • Dr. V. Bryan Lawlis, PhD
  • Independent Director
  • 360.90K
  • Dr. Gaurav Aggarwal, M.D.
  • Independent Director
  • 290.82K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More